LabCentral signs Science Exchange: outsourced services ‘increasingly important’

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/ChristianChan)
(Image: iStock/ChristianChan)

Related tags: Science exchange, Outsourcing

Cambridge-based LabCentral has signed on Science Exchange to provide its resident startups with access to outsourced services.

LabCentral is a shared laboratory workspace for life-sciences and biotech startups in Kendall Square.

With access to the Science Exchange​ marketplace, the startups will have access to more than 2,500 service providers that have been qualified through the ISO 9001-certified evaluation process.

The use of outsourced services is becoming increasingly important to life science and biotech companies large and small, and that’s true for our resident start-ups​,” Johannes Fruehauf, LabCentral co-founder and president told Outsourcing-Pharma.com.

Science Exchange has developed a unique ‘no-headache’ platform to streamline the process – making it easy to access services without having to negotiate each individual transaction​,” he added. “That was very attractive to us, since we’re all about removing barriers to help our companies meet their milestones faster and cost-effectively​.”

Science Exchange was certified under the EU-US Privacy Shield Framework​ in July of this year after completing a seven-step process to demonstrate compliance with various data protection requirements.

Also in July, the company partnered with IndieBio​ to provide the incubator with its services.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Related suppliers

Follow us

Products

View more

Webinars